Skip to main content

Table 2 Patient baseline and discharge clinical characteristics: inpatients split by adult and adolescent site *

From: A multi-centre cohort study of short term outcomes of hospital treatment for anorexia nervosa in the UK

 

INPATIENT: ADULT

INPATIENT: ADOLESCENT

DAYPATIENT: ADULT

 

Mean (SD) Admission N =150

Mean (SD) Discharge (N = 137)

Test statistics

ES

Mean (SD) Admission N = 11

Mean (SD) Discharge (N = 7)

Test statistics

ES

Mean (SD) Admission (N = 16)

Mean (SD) Discharge (N = 15)

Test statistics

ES

AGE

26.5 (8.9)

   

15.2 (1.6)

   

24.7 (5.3)

   

AGE ONSET

16.8 (5.6)

   

13.5 (1.4)

   

16.1 (4.1)

   

LENGTH ILL (YEARS)

8.2 (8.3)

   

2.0 (1.7)

   

7.3 (7.0)

   

LOWEST BMI

12.6 (1.7)

   

14.0 (2.0)

   

14.6 (1.6)

   

# PREVIOUS ADMISSIONS a

1.0 (0-2.0)

   

0.4 (0.5)

   

0 (0-2.0)

   

Treatment

            

LoS (weeks)

 

26.4 (17.9)

   

29.0 (11.9)

   

17.8 (10.4)

  

Weight gain

            

BMI

14.0 (1.7)

17.3 (2.1)

-21.4, p < .001

1.7

15.0 (1.6)

18.5 (1.3)

-5.6, p = .001

3.1

17.3 (2.4)

18.5 (2.2)

-2.1, p = .059

0.4

Weight (kgs)

38.3 (6.0)

47.1 (7.5)

-20.6, p < .001

1.3

40.8 (6.1)

50.9 (5.3)

-5.6, p = .003

2.1

45.1 (7.4)

48.4 (6.0)

-2.0, p = .065

0.4

Weekly gain (kg)

 

0.4 (0.3)

   

0.5 (0.4)

   

0.1 (0.3)

  

BMI 6 weeks*

 

15.1 (1.8)

   

15.1 (1.1)

   

17.5 (2.4)

  

6wk rate of weekly weight *

 

0.6 (0.5)

   

0.2 (0.2)

   

-0.2 (0.4)

  

Eating psychopathology (0-6) and behaviours

EDE-Q Total

4.2 (1.3)

3.3 (1.6)

6.5, p < .001

-0.6

4.1 (1.4)

3.5 (1.0)

0.3, p = .778

-0.2

4.4 (1.0)

3.7 (1.3)

2.7, p = .020

-0.7

EDE-Q Restraint

3.7 (1.8)

2.9 (1.9)

3.7, p < .001

-0.4

3.7 (2.2)

2.7 (1.2)

0.3, p = .802

-0.2

3.6 (2.0)

3.3 (1.4)

1.4, p = .186

-0.2

EDE-Q Eating Concern

3.7 (1.3)

2.8 (1.5)

6.3, p < .001

-0.6

3.6 (1.5)

3.0 (1.5)

-0.1, p = .898

-0.1

4.0 (1.1)

3.3 (1.4)

2.3, p = .041

-0.7

EDE-Q Shape Concern

5.0 (1.2)

4.1 (1.8)

5.9, p < .001

-0.5

5.2 (0.8)

4.8 (0.8)

0.8, p = .499

-0.3

5.3 (0.9)

4.5 (1.5)

2.8, p = .016

-0.8

EDE-Q Weight Concern

4.5 (1.4)

3.3 (1.7)

7.2, p < .001

-0.7

4.1 (1.7)

3.7 (1.1)

0.4, p = .729

-0.3

4.7 (1.1)

3.7 (1.4)

2.9, p = .012

-0.8

OBE: Yes

55 (37%)

37 (31%)

p = .440

-0.2

3 (38%)

3 (50%)

p = 1.0

0.3

7 (44%)

10 (67%)

p = .250

0.6

LOC: Yes

82 (59%)

62 (56%)

p = .871

-0.1

3 (43%)

2 (40%)

p = 1.0

-0.1

12 (75%)

8 (52%)

p = .625

-0.6

SIV: Yes

42 (30%)

26 (23%)

p = 1.0

-0.2

2 (29%)

1 (20%)

p = 1.0

-0.3

6 (38%)

5 (39%)

p = 1.0

0.0

LAX: Yes

29 (20%)

12 (11%)

p = .152

-0.4

0

1 (20%)

p = 1.0

-

3 (19%)

2 (15%)

p = 1.0

-0.2

DIUR: Yes

8 (6%)

0

p = .063

-

0

0

-

-

1 (6%)

2 (15%)

p = 1.0

-0.5

EXC. EX: Yes

83 (58%)

41 (37%)

p = .012

-0.5

5 (63%)

1 (20%)

p = .500

-1.2

7 (44%)

7 (54%)

p = 1.0

0.3

Mood and Quality of life

DASS total

77.8 (27.9)

64.8 (31.7)

4.9, p < .001

-0.4

75.3 (33.4)

36.0 (16.4)

1.5, p = .233

-0.9

79.1 (25.2)

67.5 (33.0)

1.1, p = .277

-0.4

DASS Depression

28.4 (11.3)

24.3 (12.7)

3.8, p < .001

-0.3

30.5 (11.8)

14.0 (8.9)

1.2, p = .309

-0.9

29.5 (10.8)

25.1 (14.7)

1.0, p = .316

-0.4

DASS Anxiety

20.3 (10.6)

15.7 (11.7)

4.5, p < .001

-0.4

15.5 (12.4)

8.4 (5.2)

p = .285

-0.4

20.1 (7.6)

18.9 (10.1)

-0.4, p = .726

-0.3

DASS Stress

29.1 (9.7)

24.7 (10.7)

4.3, p < .001

-0.4

29.3 (10.9)

13.6 (6.5)

1.9, p = .155

-1.3

29.5 (8.6)

23.5 (9.7)

1.7, p = .108

-0.7

WHO QoL (1-5)

2.4 (1.0)

3.2 (0.9)

-6.7, p < .001

0.8

2.3 (0.9)

4.0 (1.0)

-2.0, p = .141

1.6

2.9 (1.0)

2.8 (1.3)

0.4, p = .721

-0.1

WHO HEALTH (1-5)

2.3 (0.9)

2.9 (1.0)

-5.0, p < .001

0.5

3.0 (1.2)

4.2 (0.8)

-1.2, p = .308

0.6

2.4 (1.0)

2.3 (1.0)

0.4, p = .721

-0.1

WHO Psychological

26.2 (17.5)

35.5 (19.5)

-5.6, p < .001

0.5

26.0 (18.2)

46.7 (20.5)

-0.7, p = .519

0.5

22.1 (17.3)

26.3 (20.7)

-0.9, p = .378

0.2

WHO Social

40.2 (22.1)

40.8 (21.7)

0.6, p = .581

0.1

38.0 (31.6)

41.7 (25.7)

0.7, p = .537

0.3

33.3 (18.0)

26.3 (17.3)

0.3, p = .764

-0.1

WHO Physical

51.0 (20.0)

62.2 (20.8)

-5.3, p < .001

0.5

67.0 (20.4)

86.4 (8.5)

-1.6, p = .207

0.3

46.2 (18.1)

45.3 (22.6)

0.7, p = .484

-0.1

WHO Environment

52.7 (16.9)

61.2 (17.0)

-5.2, p < .001

0.4

56.6 (14.0)

72.5 (19.8)

-1.6, p = .215

0.7

53.6 (9.9)-0.2

50.3 (16.1)

1.1, p = .296

 

Motivation (1-10)

Importance to change

8.0 (2.3)

7.5 (2.5)

2.6, p = .010

-0.3

6.3 (4.3)

4.2 (3.3)

2.1, p = .127

-0.6

8.9 (1.1)

8.4 (2.5)

0.5, p = .603

-0.2

Confidence to change

5.5 (2.6)

5.4 (2.5)

1.2, p = .222

-0.1

5.0 (2.5)

6.2 (2.3)

-0.9, p = .448

0.6

5.0 (2.0)

4.7 (2.6)

0.4, p = .711

-0.3

Perceived support from carers

LEE primary carer

20.0 (15.4)

18.3 (13.8)

1.3, p = .182

-0.1

20.6 (15.0)

14.7 (6.7)

0.2, p = .858

-0.1

19.0 (9.9)

22.5 (12.9)

-1.2, p = .249

0.3

PCS Mother

2.4 (1.0)

2.4 (1.0)

-0.5, p = .633

0.0

2.0 (0.8)

1.8 (0.1)

0.5, p = .670

-0.04

2.5 (0.9)

2.5 (0.9)

-0.1, p = .902

-0.02

PCS Father

2.2 (1.0)

2.1 (0.9)

0.5, p = .618

-0.04

1.9 (0.5)

1.9 (0.3)

-0.04, p = .973

0.03

2.4 (1.0)

2.5 (1.3)

-0.4, p = .708

-0.1

  1. * Not every participant answered every question; a Median and IQR reported. b data for one site not presented in isolation as only 2 participants were inpatients; day patients are not included in individual site calculations; ES: Effect size; SD: Standard Deviation; N = sample number included; BMI: Body Mass Index; EDE-Q Eating Disorder Examination Questionnaire; OBE: Objective binge episodes with loss of control; LOC: Loss of control other than binge; SIV: Self-induced vomiting; LAX: Laxative use; EXER: Excessive exercise; DASS: Depression, Anxiety and Stress Scale; WHO: World Health Organization; QoL: Overall quality of life (1–5 high); HEALTH: Overall satisfaction with health (1–5 high); LEE: Levels of Expressed Emotion; PCS: Psychological Control Scale; Analyses for change over treatment period for adolescent and day patient samples were conducted using t-tests (data presented in table) and Wilcoxin Signed Ranks test for non-parametric data because of small sample sizes. There were no differences in the pattern of results. Bold values indicate a statistically significant result.
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us